Tristel (R1V) Stock Overview
Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
R1V Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Tristel plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£4.08 |
| 52 Week High | UK£5.35 |
| 52 Week Low | UK£3.04 |
| Beta | 0.16 |
| 1 Month Change | 0% |
| 3 Month Change | -13.92% |
| 1 Year Change | -10.53% |
| 3 Year Change | 8.51% |
| 5 Year Change | -23.88% |
| Change since IPO | -15.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| R1V | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -1.4% | 5.2% | 2.7% |
| 1Y | -10.5% | -11.4% | 14.5% |
Return vs Industry: R1V exceeded the German Medical Equipment industry which returned -13.3% over the past year.
Return vs Market: R1V underperformed the German Market which returned 15% over the past year.
Price Volatility
| R1V volatility | |
|---|---|
| R1V Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 12.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: R1V has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: R1V's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 233 | Matt Sassone | tristel.com |
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wipes, sporicidal wipes, clean for Stella, protect, and wipes; surface disinfection products, such as FUSE, JET, JET LUX, JET PRO, TANK 10 CLO2, TANK 5 CLO2, and TILT 5 CLO2; as well as operates 3T, a cloud-based platform alternative to paper-based traceability systems.
Tristel plc Fundamentals Summary
| R1V fundamental statistics | |
|---|---|
| Market cap | €198.70m |
| Earnings (TTM) | €7.05m |
| Revenue (TTM) | €50.03m |
Is R1V overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| R1V income statement (TTM) | |
|---|---|
| Revenue | UK£43.56m |
| Cost of Revenue | UK£8.10m |
| Gross Profit | UK£35.47m |
| Other Expenses | UK£29.33m |
| Earnings | UK£6.14m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Oct 13, 2025
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 81.42% |
| Net Profit Margin | 14.09% |
| Debt/Equity Ratio | 0% |
How did R1V perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 17:25 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tristel plc is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Simon Miller | Blue Oar Securities |
| Christopher Donnellan | Cavendish |
| Vadim Alexandre Khalil | Daniel Stewart & Company |